Ajanta Pharma

BSE : 532331 | NSE : AJANTPHARM

Industry : Pharma Formulations | ISIN : INE031B01049 | FreeFloat : 30.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)3,178.67
Net Worth (NW)2,598.87
Intrinsic Worth (IW)5,777.54
Market Cap (MC)11,921.62
Economic Value Added41.79
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)55.02%
IC Gross Margin (EBITDA/IC)23.23%
IC Net Margin (NPT/IC)13.87%
Knowledge Turnover (Sales/IC)0.82
Market to Intrinsic Value (MC/IW)2.06

As OfIntrinsic ValueMarket Price
31 Mar 2020Rs. 662.15Rs. 1,366.30
26 May 2020 - Rs. 1,498.30
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 1,460.38ReduceBuy on Dips
KB > 50% : Yes50 DMA : Rs. 1,363.62
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-17
C
473.12
477.88
132.22
118.80
118.73
94.79
96.60
Sep-17
C
540.38
549.56
192.91
178.36
178.27
131.89
133.57
Dec-17
C
587.05
602.20
212.65
197.67
197.53
147.47
146.69
Mar-18
C
530.31
535.55
144.77
128.13
128.02
94.49
95.48
Jun-18
C
510.99
519.12
165.62
148.45
148.28
105.79
102.27
Sep-18
C
544.11
559.35
181.46
163.97
163.84
125.39
125.93
Dec-18
C
485.11
489.52
111.72
93.05
92.96
66.90
66.71
Mar-19
C
515.16
516.79
128.71
109.96
109.19
88.89
88.83
Jun-19
C
611.94
619.58
176.02
153.24
151.45
114.63
113.33
Sep-19
C
642.76
655.98
189.79
166.49
161.56
116.36
116.50
Dec-19
C
651.21
665.85
200.27
176.67
175.10
107.55
109.38
Mar-20
C
681.96
738.65
205.52
179.48
175.86
129.16
134.05
* C - Consolidated, S - Standalone